A rare case of carcinosarcoma of breast: Coexistence of mucinous carcinoma and malignant fibrous histiocytoma

Carcinosarcoma (CS) of breast is a rare disease. Published reports provided little consensus about its clinical characteristics and optimal treatment protocols. Here we present a patient with CS of breast (mucinous carcinoma and malignant fibrous histiocytoma) and review related literature. Combined...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and therapeutics 2015-10, Vol.11 (4), p.1024
Main Authors: Liu, Min, Liu, Bailong, Song, Yanqiu, Dong, Lihua
Format: Article
Language:English
Subjects:
Adenocarcinoma, Mucinous - complications
Adenocarcinoma, Mucinous - pathology
Adenocarcinoma, Mucinous - therapy
Biopsy
Breast cancer
Breast Neoplasms - complications
Breast Neoplasms - pathology
Breast Neoplasms - therapy
Cancer therapies
Carcinoma
Care and treatment
Chemotherapy
Combined Modality Therapy
Complications and side effects
Development and progression
Female
Gene mutation
Histiocytoma, Malignant Fibrous - complications
Histiocytoma, Malignant Fibrous - pathology
Histiocytoma, Malignant Fibrous - therapy
Humans
Lymphatic system
Mastectomy
Metastasis
Middle Aged
Neoplasms, Multiple Primary - complications
Neoplasms, Multiple Primary - pathology
Neoplasms, Multiple Primary - therapy
Prognosis
Radiation therapy
Rare Diseases - complications
Rare Diseases - pathology
Rare Diseases - therapy
Risk factors
Tumors
Ultrasonic imaging
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Carcinosarcoma (CS) of breast is a rare disease. Published reports provided little consensus about its clinical characteristics and optimal treatment protocols. Here we present a patient with CS of breast (mucinous carcinoma and malignant fibrous histiocytoma) and review related literature. Combined modality treatment (CMT) brings at least 2 year disease-free survival (DFS). Our case highlights the possibility of breast CS and helps to expand our understanding of this distinct breast malignancy.
ISSN:0973-1482
1998-4138
DOI:10.4103/0973-1482.147723